FDA Approves ANDA for Tofacitinib Citrate by Auson
The FDA has approved the ANDA219370 for Tofacitinib Citrate submitted by Auson.
Asset / Drug
Drug and asset intelligence for Auson with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
JAK Inhibitor
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.